Indatuximab ravtansine (BT062) is an immunomodulator and antineoplastic antibody-drug conjugate. It is the anti-CD138 chimerized MAb (nBT062) linked to...
3 KB (198 words) - 19:21, 6 May 2024
Ravtansine is a component of several drug conjugates and may refer to: Cantuzumab ravtansine Indatuximab ravtansine Maitansine This disambiguation page...
179 bytes (48 words) - 16:05, 5 December 2023
ImmunoGen (redirect from Anetumab ravtansine)
ImmunoGen's SPDB linker is called "ravtansine" indatuximab ravtansine (BT062) targeting multiple myeloma, anetumab ravtansine (BAY94-9343) targeting mesothelin...
9 KB (778 words) - 21:19, 31 May 2024
(EGFR) cancer Inclacumab mab human selectin P cardiovascular disease Indatuximab ravtansine mab chimeric SDC1 cancer Indusatumab vedotin mab human GUCY2C cancer...
135 KB (4,013 words) - 03:57, 1 June 2024
radiation therapy It is a specific antigen on multiple myeloma cells. Indatuximab ravtansine targets this protein. It is a useful marker for plasma cells, but...
22 KB (2,522 words) - 10:04, 27 March 2024
Dinutuximab Ecromeximab§ Ensituximab§ Futuximab§ Girentuximab† Indatuximab ravtansine§ Isatuximab Loncastuximab tesirine Margetuximab Mirvetuximab soravtansine...
5 KB (368 words) - 22:00, 19 October 2020
Dinutuximab Ecromeximab§ Ensituximab§ Futuximab§ Girentuximab† Indatuximab ravtansine§ Isatuximab Loncastuximab tesirine Margetuximab Mirvetuximab soravtansine...
4 KB (241 words) - 11:41, 22 April 2022
Dinutuximab Ecromeximab§ Ensituximab§ Futuximab§ Girentuximab† Indatuximab ravtansine§ Isatuximab Loncastuximab tesirine Margetuximab Mirvetuximab soravtansine...
3 KB (129 words) - 01:04, 19 July 2023